share_log
Moomoo 24/7 ·  04/16 07:06

Voyager Therapeutics And Neurocrine Biosciences Have Selected Lead Development Candidate In GBA1 Gene Therapy Program For Potential Treatment Of Parkinson's Disease And Other GBA1-mediated Diseases

Voyager Therapeutics和Neurocrine Biosciences已在GBA1基因疗法项目中选出了潜在的帕金森氏病和其他GBA1介导疾病的潜在治疗药物的潜在开发候选人

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发